Is Everolimus covered by medical insurance?

Everolimus (Everolimus) is an oral drug that belongs to the category of immunosuppressants. It is a new type of protease inhibitor developed by Pfizer Pharmaceuticals and approved for medical use by the U.S. Food and Drug Administration (FDA) in 2009.

Everolimus has been approved for marketing in my country, and has been included in the national medical insurance. The price is about 4000~5000 yuan. It takes about 2 boxes of everolimus per month. For specific prices and medical insurance reimbursement policies, please consult the local hospital pharmacy or medical insurance bureau. The cheaper ones abroad are mainly Indian generic drugs, the price is around 700~1,500yuan, and the ingredients of the drugs are basically the same as those in China.

The main function of everolimus is to suppress the function of the immune system and reduce immune responses, thereby preventing organ rejection after organ transplantation. It can inhibit the proliferation ofTlymphocytes and block immune attacks against transplanted organs, thereby helping patients accept allogeneic organs and maintain the function of transplanted organs.

In addition, everolimus is also used in the treatment of some specific types of cancer, such as breast cancer, renal cell carcinoma, neuroendocrine tumors, etc. It is called a targeted therapy drug that inhibits the growth and spread of cancer cells by inhibiting cell proliferation signaling pathways, thereby inhibiting tumor progression.

Everolimus is also used in drug-coated stents for the treatment of coronary artery stenosis. In this case, everolimus is coated on the stent, which reduces the risk of re-stenosis within the stent by inhibiting tissue growth.

Although everolimus has many potential advantages in treatment, it may also cause some side effects and adverse reactions. Therefore, patients need to monitor closely and follow their doctor's recommendations while using everolimus to ensure safe and effective treatment. Patients should use everolimus or other medications only after evaluation and guidance by a physician.